This one actually looks a bit interesting. I was just notified by my Bell Potter broker that bids are closing early (4pm this arv) and max allocation is $15k. They don't have the inside line on how demand is but one would have to assume that's a pretty darn good sign.
A little info from the slide deck:
* First product range –Smartinhaler™ –a smart, connected device that attaches to prescription inhalers to provide reminders and monitoring, combined with the SmartinhalerLive software which makes patient data accessible via mobile applications and cloud based software.
* Cornerstone investment of US$3m from key commercial client AstraZeneca.
* 10 Year Master Supply & Development Agreement with AstraZeneca in place.
Sounds like they have a good product and actually have some revenue coming in.
Appr 40 - 55% of the shares will be escrowed (depending on size of final raising).
Existing holders buying more shares - will hold appr 50 - 64% of the company after listing.
Experienced board.
And here's a little beauty I just found in the prospectus:
"the Company’s Lead Manager has received other commitments to take up shares from its wholesale clients for a balance of funds up to $25.85 million."
So the minimum raising was more than covered before even going to market.
Certainly there seems to be a big vote of confidence from existing holders and the Lead.
- Forums
- IPOs
- Adherium Ltd
Adherium Ltd, page-3
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online